Printer Friendly

Carna Biosciences, Enamine to Collaborate in Research on Kinase.

Tokyo, Japan, May 19, 2006 - (JCN) - Carna Biosciences has concluded a joint research agreement with Ukrainian pharmaceutical company Enamine.

Under the agreement terms, the two companies will strive to identify lead compounds against kinase targets. Specifically, Enamine will create a compound library of kinases, which are related to cancer.

Carna Biosciences will screen the library, and identify and develop lead compounds. Lead compounds resulted from the collaboration effort will be licensed to other pharmaceutical companies.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:May 20, 2006
Words:85
Previous Article:J-OIL MILLS Verifies High Nutritional Value of Natto-derived Vitamin K2.
Next Article:Kagome, J-POWER to Begin Tomato Farming in Kyusyu.


Related Articles
KINEXUS VALIDATES PLK1 AS CANCER DRUG TARGET.
Faith, Carna MedSalon to Establish Joint Venture for Medical/Health Information Service.
Ambit Expands Collaboration with Bristol-Myers Squibb Company, In-Licenses Kinase Inhibitor Program Targeting Solid Tumors.
Paper in Cancer Research Further Validates Ambit Biosciences' KinomeScan Kinase Profiling Platform.
OncoTherapy Science, Carna Biosciences, CrystalGenomics to Collaborate in Development of Low-molecular Drug for Cancer.
Ambit Biosciences Adds Kinase Experts to Scientific Advisory Board and Expands Board of Directors.
Ginkgo Biomedical Research Institute, Carna Biosciences, CrystalGenomics to Collaborate in New Cancer Drug Development.
Carna Biosciences, ChemDiv to Collaborate in Creating and Marketing Annotated Kinase-focused Library.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters